Skip to content
Catalyst

adenosineFinding

Adenosine has no detected effect on all-cause mortality

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“Also, post-interventional clinical outcomes, including arrhythmia, left ventricular ejection fraction, hospitalization time, and 30 days mortality were similar between Adenosine and placebo groups.”
Quoted verbatim from Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon.
This finding among the 156 findings on its endpoint

adenosine

All-cause mortality

no difference found

Who
Patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention; intracoronary adenosine versus intracoronary normal saline; 30-day horizon
Dose studied
two intracoronary bolus doses, before and after stenting; amount not stated in the abstract

Very limited evidencePMID 32134758 · 2020

02 · The study

Study
RCT
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GC8QPYJAMDW2K341A331AK